Targeting prostacyclin: all gain with no pain?
- PMID: 37917084
- DOI: 10.1182/blood.2023022227
Targeting prostacyclin: all gain with no pain?
Comment on
-
The oxylipin analog CS585 prevents platelet activation and thrombosis through activation of the prostacyclin receptor.Blood. 2023 Nov 2;142(18):1556-1569. doi: 10.1182/blood.2023020622. Blood. 2023. PMID: 37624927 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical

